Gray Elaine, Hawkins J Ross, Morrison Marion, Hawkins Malcolm, Byrne Ed, Kitchen Steve, Jennings Ian, Makris Mike, Preston F Eric, Metcalfe Paul
National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK.
Thromb Haemost. 2006 Aug;96(2):215-9.
Forty-one laboratories participated in an international collaborative study to assess the suitability of a panel of three genomic DNA samples as the 1st International Genetic Reference Panel for the Factor V Leiden (FVL) variant. The code numbers of the materials were 03/254 (FV wild type), 03/260 (FVL homozygote) and 03/248 (FVL heterozygote). The participants evaluated the panel against their in-house controls which were known patient samples and commercial controls. In total, 859 genotype tests were carried out on the panel, with an error rate of 0.7%. The errors were not related to specific samples of the panel or to any specific techniques. The findings of this study have indicated that this panel is suitable to be used as a reference material for genotyping of factor V Leiden. It was therefore recommended that the three genomic DNA samples be established as the 1st International Genetic Reference Panel for Factor V Leiden, Human gDNA, 04/224. This recommendation was approved by the Scientific and Standardization Committee (SSC) of the ISTH (International Society on Thrombosis and Haemostasis) in June 2004 and the Expert Committee on Biological Standardization (ECBS) of the World Health Organization (WHO) in November 2004.
41个实验室参与了一项国际合作研究,以评估一组三个基因组DNA样本作为凝血因子V莱顿(FVL)变异体的首个国际遗传参考品系的适用性。这些材料的编号分别为03/254(FV野生型)、03/260(FVL纯合子)和03/248(FVL杂合子)。参与者将该组样本与他们内部已知的患者样本对照及商业对照进行评估。总共对该组样本进行了859次基因分型检测,错误率为0.7%。这些错误与该组样本的特定样本或任何特定技术无关。这项研究的结果表明,该组样本适合用作凝血因子V莱顿基因分型的参考物质。因此,建议将这三个基因组DNA样本确立为凝血因子V莱顿的首个国际遗传参考品系,人类基因组DNA,04/224。该建议于2004年6月获得国际血栓与止血学会(ISTH)科学与标准化委员会(SSC)以及2004年11月获得世界卫生组织(WHO)生物标准化专家委员会(ECBS)的批准。